问题三：公司开发的小驴伴有哪些应用场景？ 答复：小驴伴产品主要应用于提供旅行文化内容知识的线上和线下输出服 务。公司小驴伴产品聚焦于景区的 AI 识别技术及 3D 建模技术的研发，目的是研发 能搭载在景区特定 AR 眼镜上的技术解决方案，包括硬件及软件系统，实现 3D 建 模与定位、景物识别、人脸识别和识别后语音转换等，以便满足游客景区园区内自 主游览的需求，该产品正在迭代更新中。 问题四：公司如何平衡传统注塑业务与新能源汽车配件等增量业务？ 答：公司将努力保持传统注塑业务的稳健增长，同时积极拓展在新能源汽车配 件领域的业务市场。公司汽车配件类产品的主要客户包括敏实集团、均胜集团等。 证券代码：300784 证券简称：利安科技 宁波利安科技股份有限公司投资者关系活动记录表 编号：20251211 投资者关系 活动类别 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 现场参观 □其他 参会单位名称及人 员姓名 东北证券、上海卓戴资本、原道资产、友利投资、乾弘久盛及其他投资者 时间 2025 年 12 月 11 日 14:00-16:00 地点 公司 上市公司接待人员 董事长李士 ...

Group 1 - The core point of the news is that Weike Technology's stock has dropped by 5.06%, with a current price of 74.91 CNY per share and a total market capitalization of 9.383 billion CNY [1] - Weike Technology, established on April 4, 2005, and listed on January 11, 2022, is primarily engaged in the research, design, manufacturing, and sales of precision injection molds, injection products, and health products [1] - The revenue composition of Weike Technology includes injection products at 47.25%, health products at 31.33%, precision molds at 18.24%, and others at 3.19% [1] Group 2 - Among the top circulating shareholders of Weike Technology, Yongying Fund has a fund that entered the top ten shareholders, holding 3.9273 million shares, which is 4.8% of the circulating shares [2] - The fund, Yongying Advanced Manufacturing Select Mixed Fund A (018124), was established on May 4, 2023, with a latest scale of 4.697 billion CNY and has achieved a return of 72.85% this year [2] - The fund's performance ranks 236 out of 8122 in its category for the year and 99 out of 8056 for the past year, with a cumulative return of 118.62% since inception [2] Group 3 - The fund manager of Yongying Advanced Manufacturing Select Mixed Fund A is Zhang Lu, who has a tenure of 6 years and 125 days [3] - The total asset size of the fund managed by Zhang Lu is 22.921 billion CNY, with the best return during his tenure being 115.11% and the worst being -60.31% [3]

鹏华碳中和主题混合A（016530）成立日期2023年5月5日，最新规模28.3亿。今年以来收益81.68%，同 类排名128/8199；近一年收益106.08%，同类排名35/8131；成立以来收益80.26%。 鹏华碳中和主题混合A（016530）基金经理为闫思倩。 截至发稿，闫思倩累计任职时间8年48天，现任基金资产总规模188.18亿元，任职期间最佳基金回报 306.25%， 任职期间最差基金回报-0.1%。 12月1日，肇民科技涨5.11%，截至发稿，报40.33元/股，成交1.66亿元，换手率1.84%，总市值97.95亿 元。肇民科技股价已经连续5天上涨，区间累计涨幅4.72%。 资料显示，上海肇民新材料科技股份有限公司位于上海市金山区金山卫镇秦弯路633号，成立日期2011 年10月27日，上市日期2021年5月28日，公司主营业务涉及精密注塑件及配套精密注塑模具的研发、生 产和销售。主营业务收入构成为：精密注塑件-汽车部件77.41%，精密注塑件-家用电器11.83%，精密注 塑模具7.44%，其他(补充)2.98%，精密注塑件-其他0.35%。 从肇民科技十大流通股东角度 数据显示，鹏华基 ...

分红方面，利安科技A股上市后累计派现3374.26万元。 责任编辑：小浪快报 11月11日，利安科技跌0.57%，成交额3192.54万元。两融数据显示，当日利安科技获融资买入额235.43 万元，融资偿还349.35万元，融资净买入-113.92万元。截至11月11日，利安科技融资融券余额合计 7147.83万元。 融资方面，利安科技当日融资买入235.43万元。当前融资余额7147.83万元，占流通市值的7.42%，融资 余额超过近一年80%分位水平，处于高位。 融券方面，利安科技11月11日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00 元；融券余量0.00股，融券余额0.00元，超过近一年90%分位水平，处于高位。 资料显示，宁波利安科技股份有限公司位于浙江省宁波市奉化区经济开发区汇盛路289号，成立日期 2006年3月9日，上市日期2024年6月7日，公司主营业务涉及从事注塑产品以及精密注塑模具的研发、生 产和销售。主营业务收入构成为：注塑产品87.15%，精密注塑模具9.06%，其他塑料产品2.68%，其他 1.12%。 截至9月30日，利安科技股东户数8149.00， ...

Group 1 - The core viewpoint of the news is that Lian Technology has shown a mixed performance in terms of financing and stockholder metrics, with a slight increase in revenue but a decrease in net profit [1][2]. - As of November 5, Lian Technology's stock price increased by 0.17%, with a trading volume of 24.07 million yuan. The financing buy-in amount was 3.32 million yuan, while the financing repayment was 2.21 million yuan, resulting in a net financing buy-in of 1.11 million yuan [1]. - The total financing and securities balance for Lian Technology reached 72.57 million yuan, accounting for 7.58% of its market capitalization, indicating a high level of financing balance compared to the past year [1]. - The company has not engaged in any short selling activities on November 5, with a short selling balance of 0.00 yuan, which is also at a high level compared to the past year [1]. - Lian Technology's main business includes the research, production, and sales of injection molding products and precision injection molds, with revenue composition being 87.15% from injection products, 9.06% from precision molds, and 2.68% from other plastic products [1]. Group 2 - As of September 30, the number of shareholders for Lian Technology was 8,149, a decrease of 6.55% from the previous period, while the average circulating shares per person increased by 7.01% to 2,077 shares [2]. - For the period from January to September 2025, Lian Technology reported a revenue of 388 million yuan, representing a year-on-year growth of 2.48%. However, the net profit attributable to the parent company was 43.19 million yuan, reflecting a year-on-year decrease of 4.46% [2]. - Since its A-share listing, Lian Technology has distributed a total of 33.74 million yuan in dividends [3].

Group 1 - The core point of the news is that Weike Technology's stock has experienced a decline of 0.79% on November 5, with a total market value of 10.057 billion yuan and a cumulative drop of 8.23% over the past three days [1] - Weike Technology, established on April 4, 2005, specializes in precision injection molds, injection parts, and health products, with main business revenue composition being 47.25% from injection products, 31.33% from health products, 18.24% from precision molds, and 3.19% from others [1] Group 2 - The Oriental Alpha Fund's mixed fund has increased its holdings in Weike Technology by 238,600 shares in the third quarter, now holding 1.0193 million shares, which accounts for 1.24% of the circulating shares [2] - The fund has reported a floating loss of approximately 652,400 yuan today and a cumulative floating loss of 7.339 million yuan over the past three days [2] - The Oriental Alpha Fund has a year-to-date return of 49.61% and a one-year return of 47.35%, ranking 916 out of 8150 and 905 out of 8043 respectively [2]

Core Viewpoint - Weike Technology experienced a 5.03% decline in stock price, reaching 81.17 CNY per share, with a total market capitalization of 10.167 billion CNY as of November 4 [1] Company Overview - Weike Technology, established on April 4, 2005, and listed on January 11, 2022, is located in Xiamen, Fujian Province. The company specializes in the research, design, manufacturing, and sales of precision injection molds, injection products, and health products [1] - The revenue composition of Weike Technology is as follows: injection products 47.25%, health products 31.33%, precision molds 18.24%, and others 3.19% [1] Shareholder Information - The top circulating shareholder of Weike Technology is the Oriental Alpha Fund, which increased its holdings in Weike Technology by 238,600 shares in the third quarter, bringing its total to 1.0193 million shares, representing 1.24% of the circulating shares [2] - The Oriental Alpha Preferred Mixed A Fund (007518) has a year-to-date return of 56.18% and ranks 676 out of 8150 in its category [2] Fund Management - The fund manager of Oriental Alpha Preferred Mixed A is Zhou Mi, who has been in the position for 7 years and 247 days. The fund's total asset size is 3.038 billion CNY, with the best return during his tenure being 112.22% [3] Fund Holdings - Oriental Alpha Preferred Mixed A Fund has Weike Technology as its second-largest holding, accounting for 5.96% of the fund's net value, with a floating loss of approximately 4.383 million CNY as of the latest data [4]

Group 1 - The core viewpoint of the news is that Weike Technology's stock has seen a significant increase of 5.12%, reaching a price of 92.80 CNY per share, with a total market capitalization of 11.624 billion CNY [1] - Weike Technology, established on April 4, 2005, and listed on January 11, 2022, specializes in precision injection molding, injection products, and health products, with revenue contributions of 47.25% from injection products, 31.33% from health products, 18.24% from precision molds, and 3.19% from others [1] Group 2 - According to data, the Fuyong Fund has a significant holding in Weike Technology, with the Fuyong Fuxin Mixed A Fund (005164) holding 37,100 shares, accounting for 5.65% of the fund's net value, making it the third-largest holding [2] - The Fuyong Fuxin Mixed A Fund was established on March 16, 2018, with a current scale of 7.317 million CNY, and has achieved a year-to-date return of 9.08% [2] Group 3 - The fund managers of Fuyong Fuxin Mixed A Fund are Li Yanzheng and Mao Yunhong, with Li Yanzheng having a tenure of 4 years and 130 days, achieving a best fund return of 58.04% during his tenure [3] - Mao Yunhong has a tenure of 149 days, with a fund size of 4.4241 million CNY, and has achieved a best fund return of 13.6% during his tenure [3]

Group 1 - The core point of the news is that Weike Technology's stock price increased by 5.08% to 92.30 CNY per share, with a trading volume of 185 million CNY and a turnover rate of 1.63%, resulting in a total market capitalization of 11.561 billion CNY [1] - Weike Technology, established on April 4, 2005, and listed on January 11, 2022, is located in Xiamen, Fujian Province, and specializes in precision injection molding, injection products, and health product development, design, manufacturing, and sales [1] - The revenue composition of Weike Technology includes injection products at 47.25%, health products at 31.33%, precision molds at 18.24%, and others at 3.19% [1] Group 2 - Among the top circulating shareholders of Weike Technology, Qianhai Kaiyuan Fund's Qianhai Kaiyuan Jiaxin Mixed A (001765) reduced its holdings by 507,600 shares in the second quarter, now holding 946,800 shares, which is 1.4% of the circulating shares [2] - The Qianhai Kaiyuan Jiaxin Mixed A fund has achieved a year-to-date return of 79.68%, ranking 167 out of 8160 in its category, and a one-year return of 78.53%, ranking 146 out of 8026 [2] - The fund manager, Wu Guoqing, has been in position for 10 years and 31 days, with the fund's total asset size at 5.333 billion CNY and a best return of 399.41% during his tenure [3]

Group 1 - The core point of the news is that Weike Technology's stock price increased by 5.02% to 88.28 CNY per share, with a total market capitalization of 11.058 billion CNY as of the report date [1] - Weike Technology, established on April 4, 2005, is located in Xiamen, Fujian Province, and was listed on January 11, 2022. The company specializes in the research, design, manufacturing, and sales of precision injection molds, injection products, and health products [1] - The revenue composition of Weike Technology includes injection products at 47.25%, health products at 31.33%, precision molds at 18.24%, and others at 3.19% [1] Group 2 - From the perspective of major fund holdings, Guotai Fund has a significant position in Weike Technology, with the Guotai Jinma Stable Return Mixed A Fund (020005) holding 421,100 shares, accounting for 3.66% of the fund's net value [2] - The Guotai Jinma Stable Return Mixed A Fund reduced its holdings by 6,800 shares in the second quarter, and the estimated floating profit from this investment is approximately 1.777 million CNY [2] - The fund has a total scale of 776 million CNY and has achieved a year-to-date return of 32.54%, ranking 2,124 out of 8,162 in its category [2]